47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,5 | 2,5 | 1,4 | -42,4 |
EBITDA | 1,3 | 1,7 | 0,5 | -71,7 |
Short time liabilities | 9 | 9,5 | 10,5 | 10 |
Equity capital | 11,7 | 12,5 | 11,7 | -6,2 |
Operating profit (EBIT) | 1,1 | 1,6 | 0,3 | -79,3 |
Assets | 21 | 22,5 | 22,7 | 0,8 |
Net profit (loss) | 1,1 | 2 | 1,2 | -39,3 |
Cash | 2,5 | 0,3 | 0,3 | 17,7 |
Net income from sale | 46,2 | 53,5 | 56 | 4,7 |
Liabilities and provisions for liabilities | 9,4 | 10 | 10,9 | 9,6 |
Working assets | 19,9 | 21,5 | 21,6 | 0,4 |
Depreciation | 0,2 | 0,2 | 0,2 | -4,8 |
% | % | % | p.p. | |
Profitability of capital | 9,8 | 15,7 | 10,2 | -5,5 |
Equity capital to total assets | 55,5 | 55,6 | 51,8 | -3,8 |
Gross profit margin | 3,1 | 4,7 | 2,6 | -2,1 |
EBITDA Margin | 2,8 | 3,3 | 0,9 | -2,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 71 | 65 | 68 | 3 |
Current financial liquidity indicator | 2.191534996032715 | 2.237563371658325 | 2.0399749279022217 | -0,2 |
Net dept to EBITDA | -1.895787239074707 | -0.1314372569322586 | -0.2576392889022827 | -0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane